Cliff Meyer
Harvard University
H-index: 51
North America-United States
Top articles of Cliff Meyer
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Transcription factor dynamics, oscillation, and functions in human enteroendocrine cell differentiation | bioRxiv | Pratik NP Singh Wei Gu Shariq Madha Allen W Lynch Paloma Cejas | 2024 |
Cistrome Data Browser: integrated search, analysis and visualization of chromatin data | Nucleic Acids Research | Len Taing Ariaki Dandawate Sehi L’Yi Nils Gehlenborg Myles Brown | 2024/1/5 |
Search for an axion-like particle with forward proton scattering in association with photon pairs at ATLAS | C Sawyer K Zheng X Zheng Z Zheng D Zhong | 2023 | |
Multi-batch single-cell comparative atlas construction by deep learning disentanglement | Nature Communications | Allen W Lynch Myles Brown Clifford A Meyer | 2023/7/12 |
scATAnno: Automated Cell Type Annotation for single-cell ATAC-seq Data | bioRxiv | Yijia Jiang Zhirui Hu Junchen Jiang Alexander Zhu Yi Zhang | 2023/6/5 |
MetaTiME integrates single-cell gene expression to characterize the meta-components of the tumor immune microenvironment | Nature communications | Yi Zhang Guanjue Xiang Alva Yijia Jiang Allen Lynch Zexian Zeng | 2023/5/6 |
Discovery of targets for immune–metabolic antitumor drugs identifies estrogen-related receptor alpha | Cancer discovery | Avinash Sahu Xiaoman Wang Phillip Munson Jan PG Klomp Xiaoqing Wang | 2023/3/1 |
Cistrome Explorer: an interactive visual analysis tool for large-scale epigenomic data | Bioinformatics | Sehi L’Yi Mark S Keller Ariaki Dandawate Len Taing Chen-Hao Chen | 2023/2/1 |
Topical therapy for regression and melanoma prevention of congenital giant nevi | Cell | Yeon Sook Choi Tal H Erlich Max von Franque Inbal Rachmin Jessica L Flesher | 2022/6/9 |
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes | Blood cancer discovery | Eva J Schaefer Helen C Wang Hannah Q Karp Clifford A Meyer Paloma Cejas | 2022/3/1 |
A path to translation: How 3D patient tumor avatars enable next generation precision oncology | Cancer cell | Shree Bose Margarida Barroso Milan G Chheda Hans Clevers Elena Elez | 2022/12/12 |
Intrinsic bias estimation for improved analysis of bulk and single-cell chromatin accessibility profiles using SELMA | Nature Communications | Shengen Shawn Hu Lin Liu Qi Li Wenjing Ma Michael J Guertin | 2022/9/21 |
MIRA: joint regulatory modeling of multimodal expression and chromatin accessibility in single cells | Nature methods | Allen W Lynch Christina V Theodoris Henry W Long Myles Brown X Shirley Liu | 2022/9 |
MetaTiME: Meta-components of the Tumor Immune Microenvironment | bioRxiv | Yi Zhang Guanjue Xiang Alva Yijia Jiang Allen Lynch Zexian Zeng | 2022/8/6 |
BCOR and BCORL1 mutations disrupt PRC1.1 repressive function in leukemia by unlinking the RING-PCGF1 enzymatic core from target genes | bioRxiv | Eva J Schaefer Helen C Wang Clifford A Meyer Paloma Cejas Micah D Gearhart | 2021/3/8 |
Data-driven discovery of targets for bipotent anticancer drugs identifies Estrogen Related Receptor Alpha | bioRxiv | Avinash D Sahu Xiaoman Wang Phillip Munson Jan Klomp Xiaoqing Wang | 2021/10/26 |
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity | Nature Cancer | April C Watt Paloma Cejas Molly J DeCristo Otto Metzger-Filho Enid YN Lam | 2021/1 |
Accurate estimation of intrinsic biases for improved analysis of bulk and single-cell chromatin accessibility sequencing data using SELMA | bioRxiv | Shengen Shawn Hu Lin Liu Qi Li Wenjing Ma Michael J Guertin | 2021/10/24 |
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target | Cell | Xiaoqing Wang Collin Tokheim Shengqing Stan Gu Binbin Wang Qin Tang | 2021/10/14 |
Abstract P108: In vivo CRISPR screens identify E3 ligase COP1 as a modulator of macrophage infiltration and cancer immunotherapy target | Molecular Cancer Therapeutics | Xiaoqing Wang Collin Tokheim Shengqing S Gu Binbin Wang Qin Tang | 2021/12/1 |